O

Orphazyme

0 followers

Danish biopharma company, listed on Nasdaq Copenhagen, with a late-stage drug pipeline, developing new treatment options for orphan protein-misfolding diseases.

Industries

Employees

51-200

Links


Org chart

Anders Vadsholt's profile picture
Anders Fink V.
Chief Executive Officer

Board & advisors

Jakob Bendtsen
Board Member
Jakob Have
Board Member

Offices